Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Melanated Group Midwifery Care (MGMC) (MGMC)

5. Oktober 2026 aktualisiert von: Kylea Laina Liese, University of Illinois Chicago

Schwarze Hebammen für schwarze Frauen: Mutterschaftspflege, um das Vertrauen zu stärken und strukturellen Rassismus abzuschwächen

This study is being conducted to determine if a multi-level intervention for delivering maternity care can improve patient trust and engagement among Black birthing people.

Studienübersicht

Detaillierte Beschreibung

Low-risk pregnant participants will be randomized into Melanated Group Midwifery Care or usual individualized obstetric care. In Melanated Group Midwifery Care (MGMC), Black women will receive prenatal care from a Black midwife in groups with the same 8-10 other Black women throughout pregnancy. In pregnancy and into the first year postpartum, MGMC patients will stay connected to the health system through a proactive care coordinator, who is a Black licensed nurse. For the first year after giving birth, patients in MGMC will also be supported by a trained postpartum doula.

All participants (intervention and usual care groups) will complete study measures that include validated surveys on patient trust, respect and engagement at 6 time points:

  • 3 time points in pregnancy [baseline (<20 weeks), 26-28 weeks, and 35- 37 weeks] and
  • 3 in the postpartum at 2-, 6-, and 12-months
  • Additional qualitative interviews will be done to track the care received by medically and socially complex patients, including all who experience a severe maternal morbidity.

The investigators will also document how MGMC gets embedded in practice through a qualitative process evaluation.

Studientyp

Interventionell

Einschreibung (Geschätzt)

432

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Illinois
      • Chicago, Illinois, Vereinigte Staaten, 60612-7316
        • University of Illinois at Chicago

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

15 Jahre bis 49 Jahre (Kind, Erwachsene)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Weiblich

Beschreibung

Inclusion criteria for patients:

  • pregnant women who self-identify as Black on a standard prenatal intake form
  • less than 20 weeks pregnant
  • 15 years old or older
  • present to the general obstetrics group at the University of Chicago Medical Center for their new prenatal visit
  • speak and understand English

Inclusion criteria for providers:

• All black midwives, care coordinators, and community postpartum doulas at the University of Chicago are eligible to participate.

Exclusion criteria for patients:

  • having a condition for which they present to a higher level of obstetrics care (e.g., maternal fetal medicine) for their new prenatal visit
  • having a cognitive issue that impairs their ability to give informed consent.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Versorgungsforschung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Doppelt

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: MGMC Intervention Group

In the MGMC (intervention) group, pregnant women will participate in group prenatal care and have ~2-hour visits with the same two co-facilitators, a Black midwife and a Black care coordinator, along with 8-12 other Black women at a similar stage of pregnancy, for all prenatal and one postnatal care visits.

The care coordinator will proactively engage with women throughout pregnancy and up to 12 months postpartum. The care coordinator helps women make appointments, sends reminders, and follows-up to ensure care was received, understood, and was appropriate. In the 3rd trimester, women in MGMC will be introduced to a community-based postpartum doula. The doula will make home visits once before birth and within the first 2 weeks postpartum; they will have approximately 50 contact hours available for 12 months postpartum for primarily in-person support, but they will be available by phone and text.

Racially concordant maternity care Group prenatal care Racially concordant nursing care coordination Postpartum doula support

Kein Eingriff: Usual Care

In the usual care (comparator) group, pregnant women attend individually scheduled visits with a midwife or obstetrician for a physical assessment and counseling. Although this can vary by provider, continuity of care is rare and racial concordance is not a consideration. Referrals for medical or social services are given to the patient to complete in both prenatal and postnatal care.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Patient Engagement-Prenatal Adequacy
Zeitfenster: Birth (T3)

Appropriate number (yes/no) and timing of prenatal visits (yes/no) documented in electronic medical records

Birth (T3)
Patient Engagement-Prenatal Adherence
Zeitfenster: Birth (T3)

Five tests completed during prenatal period (yes/no), documented in electronic medical record

Birth (T3)
Patient Engagement-Postnatal adequacy
Zeitfenster: 1 year postpartum (T6)

Appropriate number (yes/no) and timing of postnatal visits (yes/no) documented in electronic medical record

1 year postpartum (T6)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Patient activation
Zeitfenster: Change from baseline through 12 months postpartum (T6)

Patient Activation Measure (PAM), 13-item scale, range 0-100, Likert disagree strongly to agree strongly and not applicable. Assesses degree to which individuals take an active role in managing health and health care. Higher scores are more likely to understand that their active involvement is critical to their state of health and considered more ''in charge.'' The PAM has strong psychometric properties and is predictive of a wide range of health-related behaviors. Hibbard et al. report that a 4-point difference in PAM scores can be viewed as clinically significant.

Change from baseline through 12 months postpartum (T6)
Patient Autonomy
Zeitfenster: Change from baseline through 12 months postpartum (T6)

Mothers Autonomy in Decision-Making Scale. 7 item scale, Likert completely disagree to completely agree. Assesses the degree to which patients were given decision-making for healthcare decisions, and if patients felt respected by providers. Higher scores indicate that providers supported patient autonomy and patient decision-making.

Change from baseline through 12 months postpartum (T6)
Provider Trust
Zeitfenster: Change from baseline through 12 months postpartum (T6)

Trust in Physician Scale, 11 items, range 11-55, Likert 1-5; α =0.85-0.90.

Change from baseline through 12 months postpartum (T6)
Patient Satisfaction
Zeitfenster: Change from late pregnancy (35-37 gestational weeks) (T3) and 2 months postpartum (T4)

22 items; 5-point Likert (excellent to poor); α =0.95. Excellent reliability and construct validity, taps six established dimensions of satisfaction (art of care, technical quality, access, physical environment, availability, and efficacy)

Change from late pregnancy (35-37 gestational weeks) (T3) and 2 months postpartum (T4)
Mental Well Being
Zeitfenster: Change from baseline through 12 months postpartum (T6)

Computerized Adaptive Testing - Mental Health: assessing depression, anxiety, suicidality, substance use disorder, and social determinants of health.

Change from baseline through 12 months postpartum (T6)
Respectful Care
Zeitfenster: Change from late pregnancy (35-37 gestational weeks) (T3) and 2 months postpartum (T4)

Mothers on Respect index (MORi) quantifies women's sense of disrespect and dismissal when engaging in conversation with providers, 14 items, Likert, ranging from 1-strongly disagree to 6-strongly agree. α =0.94

Change from late pregnancy (35-37 gestational weeks) (T3) and 2 months postpartum (T4)

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Medical Referrals
Zeitfenster: 12 months postpartum (T6)

Referrals to higher acuity medical or obstetric care

12 months postpartum (T6)
Social Referrals
Zeitfenster: 12 months postpartum (T^)

Referrals to higher acuity mental health or social services

12 months postpartum (T^)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Stacie L Geller, PhD, University of Illinois Chicago

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

8. Juni 2022

Primärer Abschluss (Geschätzt)

15. Januar 2027

Studienabschluss (Geschätzt)

1. August 2027

Studienanmeldedaten

Zuerst eingereicht

26. April 2022

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

3. Mai 2022

Zuerst gepostet (Tatsächlich)

9. Mai 2022

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

6. Oktober 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

5. Oktober 2026

Zuletzt verifiziert

1. Oktober 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • CHAIRb 21120101
  • AD-2020C3-21229 (Andere Zuschuss-/Finanzierungsnummer: PCORI Foundation)

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren